Genes may influence links between fish intake and cognitive decline
A review in older adults found limited, inconsistent evidence that a genetic variant may alter associations involving fish intake, fatty acid biomarkers and cognitive change.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review found a possible association between higher fish intake or omega-3 biomarker levels and slower cognitive decline among APOE-ε4 carriers. However, evidence was limited and inconsistent, and results for dementia, Alzheimer disease and cardiovascular disease conflicted. These findings do not establish that consuming fish or taking supplements prevents cognitive decline.
The studies differed enough that the authors used a narrative review instead of meta-analysis. Few studies addressed some outcomes, and the abstract does not report follow-up lengths or a pooled effect estimate.
Different measures and outcomes
The review considered fish intake alongside fatty acid biomarkers, and cognitive decline alongside dementia and cardiovascular outcomes. An association with a biomarker is not evidence that taking a supplement would produce the same result.
What the genetic signal means
APOE-ε4 was a possible modifier of the association, but the authors describe the overall evidence as inconsistent. That leaves uncertainty about whether the observed pattern reflects a dependable difference between genetic groups.
The original publication
Interactions Between Omega-3 Fatty Acids and Genetic Variants in Contributing to Cognitive Decline and Cardiovascular Disease Risk in Older Adults: A Systematic Review.
Al Qannas F, Zhou A, Gasevic D et al.
Nutr Rev · 2026
- PubMed ID
- 41818679
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.